YazanAAbuodehMDDABR

PubMed

• 53 citations
  The role of dose escalation and proton therapy in perioperative or definitive treatment of chondrosarcoma and chordoma: An analysis of the National Cancer Data Base
  Russell F. Palm, Daniel E. Oliver, G.Q. Yang, Yazan Abuodeh, Arash O. Naghavi
  Cancer. 2019-02-15
• 13 citations
  Analysis of Relapse Events After Definitive Chemoradiotherapy in Locally Advanced Non-Small-Cell Lung Cancer Patients.
  G. Daniel Grass, Arash O. Naghavi, Yazan Abuodeh, Bradford A. Perez, Thomas J. Dilling
  Clinical Lung Cancer. 2019-01-01
• 27 citations
  Patient choice for high-volume center radiation impacts head and neck cancer outcome.
  Arash O. Naghavi, M. Echevarria, Tobin Strom, Yazan Abuodeh, Puja Venkat
  Cancer Medicine. 2018-09-02

Journal Articles

• Quantitatively Excessive Normal Tissue Toxicity and Poor Target coverage in the PORT Meta-Analysis (MA): A Dosimetric Study  
  Yazan Abuodeh, Arash O. Naghavi, Michelle Echevarria, MaryLou DeMarco, Brian Tonner, Vladimir Feygelman, Craig W Stevens, Bradford A Perez, Thomas J Dilling, Clinical Lung Cancer, 1/1/2017
• Dose escalated neoadjuvant chemoradiotherapy with dose-painting intensity-modulated radiation therapy and improved pathologic complete response in locally advanced eso...  
  P. S. Venkat R. Shridhar A. O. Naghavi S. E. Hoffe K. Almhanna J. M. Pimiento J.-P. Fontaine Y. Abuodeh K. L. Meredith J. M. Frakes, Dis Esophagus, 1/1/2017
• Staged reconstruction brachytherapy has lower overall cost in recurrent soft tissue sarcoma  
  Naghavi, A. O., Gonzalez, R. J., Scott, J. G., Kim, Y., Abuodeh, Y. A., Strom, T. J., Echevarria, M., et al, J Contemp Brachytherapy, 1/1/2017
• Priming radioimmunotherapy with external beam radiation in patients with relapsed low grade non-Hodgkin lymphoma  
  Abuodeh, Y., Ahmed, K., Echevarria, M., Naghavi, A., Grass, G. D., Robinson, T. J., Tomblyn, M., et al., Therapeutic Advances in Hematology, 1/1/2017
• Having Medicaid insurance negatively impacts outcomes in patients with head and neck malignancies  
  Naghavi, A. O., Echevarria, M. I., Grass, G. D., Strom, T. J., Abuodeh, Y. A., Ahmed, K. A., Kim, Y., et al., Cancer, 1/1/2016
• Prognostic value of pre-treatment F-18-FDG PET-CT in patients with hepatocellular carcinoma undergoing radioembolization  
  Abuodeh, Y., Naghavi, A. O., Ahmed, K. A., Venkat, P. S., Kim, Y., Kis, B., Choi, J., et al., World J Gastroenterol, 1/1/2016
• Radiosensitivity differences between liver metastases based on primary histology suggest implications for clinical outcomes following SBRTPostoperative  
  Kamran A. Ahmed, Jimmy J. Caudell, Ghassan El-Haddad, Anders E. Berglund, Eric A. Welsh et al, Int J Radiat Oncol Biol Phys
• Selective nodal irradiation on basis of (18)FDG-PET scans in limited-disease small-cell lung cancer: a prospective study In regard to van Loon et al Int J Radiat Oncol...  
  Salem, A., Abuodeh, Y. and Khader, J., Int J Radiat Oncol Biol Phys
• Join now to see all

Abstracts/Posters

• Viral hepatitis associated hepatocellular carcinoma outcomes with Y-90 radioembolization.
  Abuodeh Y, ASCO Gastrointestinal Cancers Symposium, 1/1/2016
• Priming Radioimmunotherapy with External Beam Radiation in Patients with Relapsed Low-Grade Non-Hodgkin Lymphoma.
  Abuodeh YA, Ahmed KA, Echevarria M, Naghavi AO, Grass GD, Tomblyn MB, Harrison LB, Kim S, Int J Radiat Oncol Biol Phys, 1/1/2016
• Urinary and bowel quality of life after image-guided, intensity modulated radiation therapy to the prostate bed.
  Abuodeh Y, ASCO Gastrointestinal Cancers Symposium, 1/1/2016
• Using the ALBI grade as a prognostic marker for radioembolization of hepatocellular carcinoma.
  Abuodeh Y, ASCO Gastrointestinal Cancers Symposium, 1/1/2016
• Outcomes of Melanoma Brain Metastases Treated With Stereotactic Radiosurgery and Anti-PD-1 Therapy, Anti-CTLA-4 Therapy, BRAF Inhibitor, or Conventional Chemotherapy
  Abuodeh Y, ASTRO Annual Meeting, 1/1/2016
• Impact of sarcopenia evaluated using the total psoas area (TPA) in patients undergoing Y-90 radioembolization for hepatocellular carcinoma (HCC).
  Abuodeh Y, ASCO Gastrointestinal Cancers Symposium, 1/1/2016
• Contralateral Liver Hypertrophy Following Intra-arterial Radioembolization for Liver Tumors.
  Abuodeh Y, American Brachytherapy Society Annual Meeting, 1/1/2016
• The Impact of BMI on Dosimetric Quality in Low Dose Rate Prostate Brachytherapy
  Abuodeh Y, American Brachytherapy Society Annual Meeting, 1/1/2016
• Clinical Outcomes of Combined BRAF and MEK Inhibition With Stereotactic Radiation for BRAF Mutant Melanoma Brain Metastases.
  Abuodeh Y, ASTRO Annual Meeting, 1/1/2016
• Using the ALBI Grade as a Prognostic Marker for Radioembolization of Hepatocellular Carcinoma.
  Abuodeh Y, ASTRO Annual Meeting, 1/1/2016
• Quantitatively Excessive Normal Tissue Toxicity and Poor Target Coverage in the PORT Meta-Analysis (MA): A Dosimetric Study
  Abuodeh Y, ASTRO Annual Meeting, 1/1/2016
• Low-Dose-Rate Brachytherapy for Prostate Cancer in Low Resource Settings
  Abuodeh Y, ASTRO Annual Meeting, 1/1/2016
• Race Is Associated With Poor Outcomes in Head and Neck Cancer
  Abuodeh Y, ASTRO Annual Meeting, 1/1/2016
• Staged Reconstruction Brachytherapy Has Lower Overall Cost in Recurrent Soft Tissue Sarcoma
  Abuodeh Y, ASTRO Annual Meeting, 1/1/2016
• Risk Factors for Recurrence in Human Papillomavirus-Positive Oropharyngeal Cancer
  Abuodeh Y, ASTRO Annual Meeting, 1/1/2016
• Concurrent Chemotherapy in Elderly Patients with Head and Neck Cancer
  Abuodeh Y, ASTRO Annual Meeting, 1/1/2016
• Impact of Sarcopenia Evaluated Using the Total Psoas Area (TPA) in Patient Undergoing Y-90 Radioembolization for Hepatocellular Carcinoma (HCC).
  Abuodeh Y, ASTRO Annual Meeting, 1/1/2016
• Postoperative Fractionated Stereotactic Radiation Therapy (FSRT) With 5 Gy X 5 Fractions for Brain Metastases.
  Abuodeh Y, ASTRO Annual Meeting, 1/1/2015
• Medicaid Independently Predicts for Poor Outcome in Head and Neck Malignancies.
  Abuodeh Y, ASTRO Annual Meeting, 1/1/2015
• The Potential Role for 18F-FDG PET/CT Scan as an Imaging Biomarker in Unresectable Hepatocellular Carcinoma.
  Abuodeh Y, ASTRO Annual Meeting, 1/1/2015
• Predictive biomarkers for control and survival in unresectable hepatocellular carcinoma treated with radioembolization.
  Yazan Abuodeh, Arash Naghavi, Puja Venkat, Sarah Hoffe, Ghassan El-Haddad, RSNA Annual Meeting, 1/1/2015
• The impact of FDG-PET/CT on the management of gynecologic cancers: A retrospective study.
  Ramiz Ahmad Abu-Hijlih, Akram Al-Ibraheem, Yazan Abuodeh, Imada A. Jaradat; King Hussein Cancer Center, J Clin Oncol, ASCO Annual Meeting, 1/1/2013
• Pilot Study of the feasibility and the gain of implementing Three Dimensional Conformal Radiotherapy (3DCRT) Partial Breast Irradiation (PBI) in a developing country: ...
  Abuodeh Y, GAP Meeting, 1/1/2013
• Comparative Outcomes for 3D Conformal Versus Intensity Modulated Radiation Therapy for Esophageal.
  Abuodeh Y, ASCO 2013 Gastrointestinal Cancers Symposium, 1/1/2013
• Review of patients with brain metastasis treated with fractionated stereotactic radiation therapy to surgical resection cavity.
  Abuodeh Y, ASTRO Annual Meeting, 1/1/2012
• Join now to see all